{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:45:41Z","timestamp":1791895541673,"version":"4.3.4"},"reference-count":74,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1053\/j.ajkd.2023.04.003","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T13:47:34Z","timestamp":1687614454000},"page":"543-558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Vitamin D Therapy in Adults With CKD: A Systematic Review and Meta-analysis"],"prefix":"10.1053","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3387-3743","authenticated-orcid":false,"given":"Wing-Chi G.","family":"Yeung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suetonia C.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni F.M.","family":"Strippoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasir","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmel M.","family":"Hawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel D.","family":"Toussaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil V.","family":"Badve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1053\/j.ajkd.2023.04.003_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease\u2014a systematic review and meta-analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS One"},{"issue":"9818","key":"10.1053\/j.ajkd.2023.04.003_bib2","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","article-title":"Prevalence of chronic kidney disease in China: a cross-sectional survey","volume":"379","author":"Zhang","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1053\/j.ajkd.2023.04.003_bib3","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ki.2015.230","article-title":"A\u00a0systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010","volume":"88","author":"Mills","year":"2015","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2023.04.003_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7326\/0003-4819-140-1-200401060-00006","article-title":"The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease","volume":"140","author":"Muntner","year":"2004","journal-title":"Ann Intern Med"},{"issue":"113","key":"10.1053\/j.ajkd.2023.04.003_bib5","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","year":"2009","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"10.1053\/j.ajkd.2023.04.003_bib6","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1053\/j.ajkd.2005.02.029","article-title":"Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States","volume":"45","author":"LaClair","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2023.04.003_bib7","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1111\/j.1523-1755.2005.00603.x","article-title":"25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy","volume":"68","author":"Coen","year":"2005","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2023.04.003_bib8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11255-010-9723-x","article-title":"Vitamin D insufficiency and bone fractures in patients on maintenance hemodialysis","volume":"43","author":"Ambrus","year":"2011","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2023.04.003_bib9","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/ki.2013.547","article-title":"The three-year incidence of fracture in chronic kidney disease","volume":"86","author":"Naylor","year":"2014","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ajkd.2023.04.003_bib10","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1681\/ASN.2005111194","article-title":"Relationship between moderate to severe kidney disease and hip fracture in the United States","volume":"17","author":"Nickolas","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2023.04.003_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archinte.167.2.133","article-title":"Renal function and risk of hip and vertebral fractures in older women","volume":"167","author":"Ensrud","year":"2007","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1053\/j.ajkd.2023.04.003_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/j.ajkd.2007.08.019","article-title":"Increased risk of hip fracture among men with CKD","volume":"51","author":"Dooley","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2023.04.003_bib13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ki.2013.279","article-title":"High rates of death and hospitalization follow bone fracture among hemodialysis patients","volume":"85","author":"Tentori","year":"2014","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2023.04.003_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00223-015-0070-x","article-title":"Advanced age, high beta-CTX levels, and impaired renal function are independent risk factors for all-cause one-year mortality in hip fracture patients","volume":"98","author":"Gulin","year":"2016","journal-title":"Calcif Tissue Int"},{"key":"10.1053\/j.ajkd.2023.04.003_bib15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12882-015-0099-0","article-title":"Mortality and complications after hip fracture among elderly patients undergoing hemodialysis","volume":"16","author":"Lin","year":"2015","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2023.04.003_bib16","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0272-6386(04)00958-8","article-title":"Increased risk of mortality associated with hip fracture in the dialysis population","volume":"44","author":"Mittalhenkle","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2023.04.003_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00223-008-9206-6","article-title":"Association of reduction in bone mineral density with mortality in male hemodialysis patients","volume":"84","author":"Kohno","year":"2009","journal-title":"Calcif Tissue Int"},{"issue":"9","key":"10.1053\/j.ajkd.2023.04.003_bib18","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/nep.12286","article-title":"Annual decline in estimated glomerular filtration rate is a risk factor for cardiovascular events independent of proteinuria","volume":"19","author":"Nagai","year":"2014","journal-title":"Nephrology"},{"issue":"19","key":"10.1053\/j.ajkd.2023.04.003_bib19","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Guti\u00e9rrez","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.ajkd.2023.04.003_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12882-017-0705-4","article-title":"Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD","volume":"18","author":"Krishnasamy","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1053\/j.ajkd.2023.04.003_bib21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bone.2016.11.012","article-title":"Vascular calcification in CKD-MBD: roles for phosphate, FGF23, and Klotho","volume":"100","author":"Yamada","year":"2017","journal-title":"Bone"},{"issue":"6","key":"10.1053\/j.ajkd.2023.04.003_bib22","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1681\/ASN.2019020117","article-title":"Arterial stiffness in the heart disease of CKD","volume":"30","author":"Zanoli","year":"2019","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.04.003_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2215\/CJN.02110217","article-title":"FGF23 and left ventricular hypertrophy in children with CKD","volume":"13","author":"Mitsnefes","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.04.003_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.numecd.2020.08.028","article-title":"Left ventricular hypertrophy in chronic kidney disease: a diagnostic criteria comparison","volume":"31","author":"Nardi","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2023.04.003_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2215\/CJN.06490711","article-title":"The risk for medial arterial calcification in CKD","volume":"7","author":"Hassan","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2023.04.003_bib26","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2023.04.003_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO chronic kidney disease\u2013mineral and bone disorder (CKD-MBD) guideline update: what\u2019s changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2023.04.003_bib28","first-page":"CD008175","article-title":"Vitamin D compounds for people with chronic kidney disease not requiring dialysis","volume":"4","author":"Palmer","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.ajkd.2023.04.003_bib29","first-page":"CD005633","article-title":"Vitamin D compounds for people with chronic kidney disease requiring dialysis","volume":"4","author":"Palmer","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1053\/j.ajkd.2023.04.003_bib30","doi-asserted-by":"crossref","first-page":"840","DOI":"10.7326\/0003-4819-147-12-200712180-00004","article-title":"Meta-analysis: vitamin D compounds in chronic kidney disease","volume":"147","author":"Palmer","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2023.04.003_bib31","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1053\/j.ajkd.2023.04.003_bib32","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"24","key":"10.1053\/j.ajkd.2023.04.003_bib33","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1002\/sim.1009","article-title":"A\u00a0refined method for the meta-analysis of controlled clinical trials with binary outcome","volume":"20","author":"Hartung","year":"2001","journal-title":"Stat Med"},{"key":"10.1053\/j.ajkd.2023.04.003_bib34","author":"Deeks"},{"issue":"4","key":"10.1053\/j.ajkd.2023.04.003_bib35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"4","key":"10.1053\/j.ajkd.2023.04.003_bib36","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000188515","article-title":"Bone mineral density evaluated by dual-energy X-ray absorptiometry after one-year treatment with calcitriol started in the predialysis phase of chronic renal failure","volume":"69","author":"Przedlacki","year":"1995","journal-title":"Nephron"},{"issue":"4","key":"10.1053\/j.ajkd.2023.04.003_bib37","first-page":"185","article-title":"Controlled trial of calcitriol in hemodialysis patients","volume":"26","author":"Baker","year":"1986","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ajkd.2023.04.003_bib38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-2369-15-130","article-title":"The influence of vitamin D analogs on calcification modulators, N-terminal pro-B-type natriuretic peptide and inflammatory markers in hemodialysis patients: a randomized crossover study","volume":"15","author":"Hansen","year":"2014","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.04.003_bib39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.ajkd.2011.06.027","article-title":"Paricalcitol versus ergocalciferol for secondary hyperparathyroidism in CKD stages 3 and 4: a randomized controlled trial","volume":"59","author":"Kovesdy","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2023.04.003_bib40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2369-15-50","article-title":"Cardiovascular effects of cholecalciferol treatment in dialysis patients\u2014a randomized controlled trial","volume":"15","author":"Mose","year":"2014","journal-title":"BMC Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2023.04.003_bib41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00223-021-00844-1","article-title":"Vitamin D supplementation for patients with chronic kidney disease: a systematic review and meta-analyses of trials investigating the response to supplementation and an overview of guidelines","volume":"109","author":"Christodoulou","year":"2021","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"10.1053\/j.ajkd.2023.04.003_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10611","article-title":"Vitamin D analogues and fracture risk in chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials","volume":"6","author":"Khelifi","year":"2022","journal-title":"JBMR Plus"},{"issue":"24","key":"10.1053\/j.ajkd.2023.04.003_bib43","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1001\/jama.2017.19344","article-title":"Association between calcium or vitamin d supplementation and fracture incidence in community-dwelling older adults: a systematic review and meta-analysis","volume":"318","author":"Zhao","year":"2017","journal-title":"JAMA"},{"issue":"12","key":"10.1053\/j.ajkd.2023.04.003_bib44","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.17789","article-title":"Vitamin D and calcium for the prevention of fracture: a systematic review and meta-analysis","volume":"2","author":"Yao","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1053\/j.ajkd.2023.04.003_bib45","first-page":"SA-PO184","article-title":"Active vitamin D use and fractures in hemodialysis patients: Results from the International DOPPS","author":"Komaba","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2023.04.003_bib46","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1053\/j.ajkd.2007.02.264","article-title":"Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis","volume":"49","author":"Jamal","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2023.04.003_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11914-005-0005-y","article-title":"The relationship between bone mineral density and fracture risk","volume":"3","author":"McClung","year":"2005","journal-title":"Curr Osteoporos Rep"},{"issue":"8","key":"10.1053\/j.ajkd.2023.04.003_bib48","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S2213-8587(20)30159-5","article-title":"Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials","volume":"8","author":"Black","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"10.1053\/j.ajkd.2023.04.003_bib49","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1007\/s00198-021-05975-7","article-title":"Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism","volume":"32","author":"Evenepoel","year":"2021","journal-title":"Osteoporos Int"},{"issue":"9","key":"10.1053\/j.ajkd.2023.04.003_bib50","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1210\/jc.2004-2552","article-title":"A\u00a0new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial","volume":"90","author":"Matsumoto","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1053\/j.ajkd.2023.04.003_bib51","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bone.2011.07.011","article-title":"A\u00a0new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures\u2014a randomized, active comparator, double-blind study","volume":"49","author":"Matsumoto","year":"2011","journal-title":"Bone"},{"issue":"6","key":"10.1053\/j.ajkd.2023.04.003_bib52","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s00774-019-01009-9","article-title":"Eldecalcitol increases bone\u00a0mineral density in Chinese osteoporotic patients without vitamin D or calcium supplementation","volume":"37","author":"Jiang","year":"2019","journal-title":"J\u00a0Bone Miner Metab"},{"issue":"4","key":"10.1053\/j.ajkd.2023.04.003_bib53","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s00774-020-01091-4","article-title":"Eldecalcitol is superior to alfacalcidol in maintaining bone mineral density in glucocorticoid-induced osteoporosis patients (e-GLORIA)","volume":"38","author":"Matsumoto","year":"2020","journal-title":"J\u00a0Bone Miner Metab"},{"issue":"1","key":"10.1053\/j.ajkd.2023.04.003_bib54","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ki.2008.501","article-title":"Vitamin D levels and patient outcome in chronic kidney disease","volume":"75","author":"Ravani","year":"2009","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2023.04.003_bib55","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.2215\/CJN.00260109","article-title":"Vitamin D affects survival independently of vascular calcification in chronic kidney disease","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2023.04.003_bib56","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","article-title":"Vitamin D levels and early mortality among incident hemodialysis patients","volume":"72","author":"Wolf","year":"2007","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2023.04.003_bib57","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/j.ajkd.2011.03.020","article-title":"Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies","volume":"58","author":"Pilz","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2023.04.003_bib58","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2369-14-199","article-title":"Vitamin D supplementation and mortality risk in chronic kidney disease: a meta-analysis of 20 observational studies","volume":"14","author":"Zheng","year":"2013","journal-title":"BMC Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2023.04.003_bib59","doi-asserted-by":"crossref","first-page":"O15","DOI":"10.1186\/1745-6215-16-S2-O15","article-title":"Using the UK renal registry for a clinical trial in dialysis patients: the example of SIMPLIFIED","volume":"16","author":"Bond","year":"2015","journal-title":"Trials"},{"issue":"5","key":"10.1053\/j.ajkd.2023.04.003_bib60","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"New Engl J Med"},{"issue":"9","key":"10.1053\/j.ajkd.2023.04.003_bib61","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.2215\/CJN.02010309","article-title":"Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD","volume":"4","author":"Agarwal","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2023.04.003_bib62","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.3390\/nu13103603","article-title":"Vitamin D and\u00a0cardiovascular disease: current evidence and future perspectives","volume":"13","author":"Cosentino","year":"2021","journal-title":"Nutrients"},{"issue":"5","key":"10.1053\/j.ajkd.2023.04.003_bib63","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1681\/ASN.2021101327","article-title":"Interventions to attenuate vascular calcification progression in chronic kidney disease: a systematic review of clinical trials","volume":"33","author":"Xu","year":"2022","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2023.04.003_bib64","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jacc.2020.09.619","article-title":"Supplemental vitamins and minerals for cardiovascular disease prevention and treatment: JACC Focus Seminar","volume":"77","author":"Jenkins","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1053\/j.ajkd.2023.04.003_bib65","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2215\/CJN.03000311","article-title":"Efficacy and safety of paricalcitol therapy for chronic kidney disease: a meta-analysis","volume":"7","author":"Cheng","year":"2012","journal-title":"Clinical J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2023.04.003_bib66","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00059-017-4605-y","article-title":"Effects of paricalcitol on cardiovascular outcomes and renal function in patients with chronic kidney disease","volume":"43","author":"Hu","year":"2018","journal-title":"Herz"},{"issue":"11","key":"10.1053\/j.ajkd.2023.04.003_bib67","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1681\/ASN.2013030203","article-title":"Active vitamin D treatment for reduction of residual proteinuria: a systematic review","volume":"24","author":"De Borst","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"suppl 3","key":"10.1053\/j.ajkd.2023.04.003_bib68","first-page":"S41","article-title":"An open label, randomized controlled study of oral calcitriol for the treatment of proteinuria in patients with diabetic kidney disease","volume":"95","author":"Krairittichai","year":"2012","journal-title":"J\u00a0Med Assoc Thai"},{"issue":"9752","key":"10.1053\/j.ajkd.2023.04.003_bib69","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","article-title":"Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial","volume":"376","author":"De Zeeuw","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.ajkd.2023.04.003_bib70","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.ajkd.2011.09.014","article-title":"Oral Calcitriol for reduction of proteinuria in patients with IgA nephropathy: a randomized controlled trial","volume":"59","author":"Liu","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1053\/j.ajkd.2023.04.003_bib71","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1002\/ptr.7139","article-title":"The effect of vitamin D supplementation on fibroblast growth factor-23 in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"35","author":"Karimi","year":"2021","journal-title":"Phytother Res"},{"issue":"6","key":"10.1053\/j.ajkd.2023.04.003_bib72","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/ejcn.2017.59","article-title":"Effects of vitamin D or its analogues on the mortality of patients with chronic kidney disease: an updated systematic review and meta-analysis","volume":"71","author":"Lu","year":"2017","journal-title":"Eur J Clin Nutr"},{"issue":"2","key":"10.1053\/j.ajkd.2023.04.003_bib73","first-page":"517","article-title":"Calcifediol supplementation in adults on hemodialysis: a randomized controlled trial","volume":"35","author":"Morrone","year":"2022","journal-title":"J\u00a0Nephrol"},{"issue":"22","key":"10.1053\/j.ajkd.2023.04.003_bib74","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1001\/jama.2018.17749","article-title":"Effect of oral alfacalcidol on clinical outcomes in patients without secondary hyperparathyroidism receiving maintenance hemodialysis: the J-DAVID randomized clinical trial","volume":"320","author":"Shoji","year":"2018","journal-title":"JAMA"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638623006935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638623006935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:49:29Z","timestamp":1759463369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638623006935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0272638623006935"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.04.003","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D Therapy in Adults With CKD: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}